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Abstract 
BACKGROUND: Pulmonary haemorrhage (PH) is a serious complication during Systemic Lupus Erythematosus 
(SLE). 
AIM: The aim was to present data on 12 patients of SLE with classic symptoms and signs of PH admitted 
throughout eleven years. 
METHODS: This retrospective study was carried out at King Abdul Aziz Specialist hospital in Taif-a tertiary care 
hospital in the western region of Saudi Arabia. The data was analysed from the case files of SLE patients who 
had episodes of PH throughout 11 years (January 2007 to December 2017).  
RESULTS: Twelve patients (10 females and 2 males) were found to have diffuse pulmonary haemorrhage during 
their SLE in the study period. Of 12 patients with confirmed pulmonary haemorrhage (hemoptysis, hypoxemia, 
new infiltrates on chest radiography, fall in haemoglobin and hemorrhagic returns of bronchoalveolar lavage with 
hemosiderin-laden macrophages) 4 patients had PH as the first presentation of SLE and 8 patients developed this 
complication during the disease. All patients presented with shortness of breath and hemoptysis. The most 
common extra-pulmonary involvement in the study cohort was renal (83%), which ranged from clinical nephritis, 
nephrotic syndrome to acute renal failure. All patients were managed in intensive care of the hospital, and of 12 
patients, 9 (75%) required mechanical ventilation. All patients were uniformly treated with pulse 
Methylprednisolone; 9 received Cyclophosphamide, 6 received IVIG, and 4 received Plasmapheresis. Only 3 
patients (25%) survived despite maximum possible support during their mean hospital stay of 18 ± 5 days. 
CONCLUSION: The requirement of mechanical ventilation and the association of renal and neuropsychiatric 
complications predicted mortality in patients with pulmonary haemorrhage. 
 
 
 
 
 
 
 
Introduction 
 
With its chronic and relapsing course, SLE 
can involve many organ systems, and pulmonary 
haemorrhage (PH) remains the devastating 
complication of this disease. The frequency of PH 
ranges from 0.63 to 5.4% in various cohorts of SLE 
[1]. While in admitted patients PH ranges from 0.5 to 
9% [2], [3] of hospital admissions, the frequency of 
this complication steeps to 5.7% in an intensive care 
setting. Further, various autopsy series in SLE 
patients have demonstrated PH up to 12.3% 
connoting clinical PH to be the tip of the iceberg [4], 
[5]. The frequency of PH is higher in women as SLE is 
more common in this gender and the mean or median 
progression of SLE at the time of PH varies from 6 
months to 14.1 years. The usual presentation of PH is 
shortness of breath with or without hemoptysis. 
However, the absence of hemoptysis in SLE patients 
doesn’t rule out PH in a given case. The presence of 
radiological evidence of infiltrates on CT scan with a 
corresponding drop in haemoglobin is the usual 
scenario among SLE cases with PH. The high-
resolution CT scan is more sensitive than 
conventional radiography in detecting PH [6]. The 
characteristic features on imaging are diffuse bilateral 
alveolar infiltrates in most series and some 
researchers have reported alveolar-interstitial 
infiltrates as well. There is a paucity of data regarding 
the type of immune response that triggers PH in 
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patients with SLE. In an animal model of PH pristane-
induced SLE in susceptible mice, the involvement of 
the innate immune response was shown to have 
played a key role. The severity or recovery from the 
insult of PH is dependent on adaptive immunity with 
significant participation of B cells. The haemorrhage 
has been shown to be preceded by infiltration of 
macrophages and neutrophils [7]. 
Regarding lung biopsy, some of the first 
studies by Myers and Katzenstein [8], demonstrated 
the small vessel vasculitis or microangitis in 4 patients 
with lupus. The above study highlights the 
characteristic expression of PH in SLE and immune 
complex deposits. Capillaritis may have immune 
complexes associated with SLE [9]. We reiterate that 
many patients with PH in SLE described in the 
literature are reported with “soft bleeding” or without 
capillaritis. 
We at this moment present data on 12 
patients of SLE with classic symptoms and signs of 
PH admitted throughout eleven years.  
 
 
Methods 
 
This was a retrospective study conducted to 
assess the predictors of mortality due to pulmonary 
haemorrhage during SLE at King Abdul Aziz 
Specialist, Taif, Saudi Arabia. All patients with PH 
fulfilled the criteria of Systemic Lupus International 
Collaborating Clinics (SLICC) group [10]. 
Patients with signs of alveolar haemorrhage 
like hemoptysis, hypoxemia, new infiltrate on chest 
radiography fall in haemoglobin concentration, and 
hemorrhagic returns of bronchoalveolar lavage with 
hemosiderin-laden macrophages were included. 
The detailed history and thorough clinical 
examination were tabulated. Patients previously 
diagnosed to have SLE were studied regarding their 
disease manifestation and the treatment modalities 
before PH. 
The laboratory investigations included 
complete blood counts, erythrocyte sedimentation rate 
(ESR) serum complement (C3, C4), autoimmune 
profile, urine analysis, coagulation, hepatic and renal 
functions were tabulated in the study cohort. 
Appropriate microbiological cultures data was 
tabulated as well. 
The chest x-ray and CT scans were analysed, 
and patients with characteristic alveolar 
haemorrhages were included. Patients who were 
diagnosed with SLE previously, their records were 
reviewed.  
Exclusion criteria: Pulmonary haemorrhage 
due to Pulmonary, renal syndromes Good pastures 
syndrome, Wegner’s Granulomatosis; Necrotising 
pneumonia; 
Data were statistically described regarding 
frequencies (number of cases) and valid percentages 
for categorical variables. Mean, standard deviations, 
minimum and maximum were used to describe 
parametric numerical variable while median and inter-
quartile range (IQR) were considered for non-
parametric data. Comparison of categorical variables 
between the subgroups (cross-tabulation) was made 
using a Chi-square test. All statistical calculations 
were done using computer program IBM SPSS 
(Statistical Package for the Social Science; IBM Corp, 
Armonk, NY, USA) release 21 for Microsoft Windows. 
 
 
Results 
 
A total of 14 patients were found to have 15 
episodes of pulmonary haemorrhage during the study 
period. The data on two patients were excluded as 
they had necrotising pneumonia. Finally, data on 12 
SLE patients with PH was analysed. 
The mean ± SD age of participants was 25.8 
± 8.3 years, and age ranged from 17-52 years. Of 12 
patients, 8 patients 8/12 (66%) were known cases of 
SLE and 4 patients (33%) PH was the first 
presentation of SLE, as shown in Figure 1.  
All the patients presented with hemoptysis 
(100%) in our series, 9 patients (75%) had shortness 
of breath, and 8 patients (66%) had coughed. 
Dyspnea at rest was mild, to begin with, and of 12 
patients, the shortness of breath rapidly worsened 
necessitating mechanical ventilation in 9/12 (75%) 
patients. Only 2 patients (16%) had a fever and florid 
signs of sepsis. While as 7 patients (58%) had 
constitutional symptoms characteristic of SLE. 
 
Figure 1: Clinical characteristics of SLE patients with Pulmonary 
haemorrhage 
 
The characteristic rash of SLE was seen in 6 
patients (50%) and musculoskeletal involvement was 
observed in 5 patients (40%) of patients in the study 
cohort. Five patients (40%) had serositis in the form of 
pericardial effusion. Of 12 patients, 3 (55%) had 
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central nervous system involvement of SLE in the 
form of seizures. The details are shown in Figure 2. 
Severe disease activity according to SLE 
disease activity index was observed in 9, while 
moderate activity in 3 patients. 
 
Figure 2: Extra Pulmonary involvement in PH patients 
 
All patients in our study cohort were found to 
have severe anaemia, normal platelets and normal 
coagulation profiles as shown in Table 1. The chest 
radiographs and HRCT revealed diffuse alveolar 
infiltrates in all patients. Bronchoalveolar lavage in 5 
patients revealed uniformly hemorrhagic fluid with 
hemosiderin-laden macrophages. In three patients 
BAL grew Acinetobacter on culture, Table 1. 
Table 1: Investigative profile of SLE patients with pulmonary 
haemorrhage 
No Age Hb WBC Platelets INR 
Cre
ate 
24 Hr 
UP 
C3 
/C4 
ANA 
dsDNA 
ECHO BAL 
1 18/F 7.9 3.8 145 1.2 1.5 1.2 Low Positive Normal Sterile 
2 52/F 6.9 3.8 132 1.1 6 1.8 Low Positive Moderate MS 
 
Sterile 
3 22/M 7.9 3.9 116 1.2 1.5 1.5gm Low Positive 
Global 
hypokinesia 
Sterile 
4 19/F 6.8 7.3 150 1.1 2.9 3.9 Low Positive 
Pericardial 
Effusion 
Sterile 
5 26/F 7.9 6.1 248 0.9 1.2 3.2 Low Positive 
Pericardial 
Effusion 
Sterile 
6 26/F 5.3 2.4 204 1.4 2.2 8gm Low Positive 
Marantic 
Endocarditis 
Acineto
bacter 
7 17/M 6.5 8.2 136 1.3 3.7 3.7gm Low Positive Normal Sterile 
8 27/F 6.2 2.3 154 1.4 3.2 6.6gm Low Positive 
Pericardial 
Effusion 
Acineto
bacter 
9 33/F 7.9 4.5. 155 1.1 1.9 6.9gm Low Positive 
Pericardial 
Effusion 
Sterile 
10 23/F 7 7.4 273 1.3 5.4 2-4gm Low Positive 
Pericardial 
Effusion 
Sterile 
11 23/F 7.5 7.1 258 1.7 1.9 2.6gm Low Positive Normal 
Acineto
bacter 
12 43/F 6.9 6.9 153 1.1 7 3gm Low Positive Normal Sterile 
 
Echocardiography was normal in 4/12 (34%) 
while as pericardial effusion was seen in 5 patients, 
one patient had marantic endocarditis, and the other 
had global hypokinesia. The pericardial effusion 
improved in 3 without drainage. Moderate Mitral 
stenosis was seen in one of the patients. The details 
are shown in Table 1. 
The patients with PH were managed in 
intensive care of the hospital. All patients received 
pulse Methylprednisolone, IVIG had been given to 6 
(50%), and 4 (33%) had received plasmapheresis. Of 
12 patients with PH 9 patients succumbed despite 
maximum available supportive treatment. Thus the 
mortality rate was 75% (9/12) in this study.  The cause 
of death was respiratory failure compounded by 
polymicrobial sepsis in 3 patients and Varicella 
pneumonia after Immunosuppression therapy was 
observed in one patient who succumbed.  
Three patients who survived episodes of PH 
didn’t require mechanical ventilation and had no 
sepsis. They were treated with pulse steroids and 
IVIG while as plasmapheresis was given to one as 
shown in Table 2. However, all the three had active 
disease, anaemia and renal derangements but none 
of the three patients had neuropsychiatric 
manifestations. 
Table 2: Management & outcome of SLE patients with 
pulmonary haemorrhage 
No Age BT M.V Steroids IVIG PF Outcome 
1 18/F 1unit NO YES YES NO SURVIVED 
2 52/F 2units YES YES NO NO DIED 
3 22/M 0 YES YES YES NO DIED 
4 19/F 2units YES YES NO NO DIED 
5 26/F 1 NO YES YES NO SURVIVED 
6 26/F 2units YES YES YES YES DIED 
7 17/M 1unit YES YES NO NO DIED 
8 27/F 0 YES YES NO NO DIED 
9 33/F 2units YES YES YES YES DIED 
10 23/F 0 NO YES NO YES SURVIVED 
11 23/F 2 YES YES NO NO DIED 
12 43/F 2 YES YES YES YES DIED 
Abbreviation used BT = Blood transfusion; M.V = Mechanical ventilation; IVIG = 
Intranvenous immunoglobulins; PF = Plasmapheresis. 
 
All the three patients who survived are on our 
follow up for the last two years now. Two patients are 
in remission, and one patient is on maintenance 
hemodialysis. Details are shown in Table 3.  
Table 3: Clinical and investigative profile of patients who 
survived 
No Age 
SLE 
duration 
Hb WBC 
Platelet
s 
INR Create 
24 Hr 
UP 
C3 
&C4 
ANA 
dsDNA 
ECHO 
Treatmen
t +No MV 
1 18/F First 7.9 3.8 145 1.2 1.5 1.2 Low Positive Normal S+IVIG 
2 26/F 6 M 7.9 6.1 248 0.9 1.2 3.2 Low Positive 
Pericardial 
Effusion 
S+IVIG+ 
3 23/F 18M 7 7.4 273 1.3 5.4 2.4 Low Positive 
Pericardial 
Effusion 
S+IVIG+P
F 
Hb = gm/dl; S-STEROIDS; IVIG = Intravenous immunoglobulin; PF = Plasmapheresis; MV 
=  Mechanical ventilation; Seizures: None; Sepsis: None; Blood transfusion: None; 
Patients 1 and 2 are in remission while as patient number 3 is on maintenance 
Hemodialysis. 
 
 
Discussion 
 
The classical triad of hemoptysis, abrupt fall in 
haemoglobin level and new lung infiltrate on CT scan 
chest were observed in all the patients in this study. 
However, overt hemoptysis may not be present in all 
SLE patients presenting with PH as reported by 
Zamora et al., [9], which means thereby that a 
physician needs to have a high degree of clinical 
suspicion in a given case of SLE presenting with 
shortness of breath and radiological changes. Even at 
high altitudes PH should not be confused with high 
altitude pulmonary oedema as reported by Lis et al., 
[11]. PH is one of the rare but catastrophic 
complications in the course of SLE, and the mortality 
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continues to be high as was observed in this study. 
We observed that patients requiring mechanical 
ventilation had a poor outcome in line with other 
workers [1], [9]. Mechanical ventilation (MV) per se 
predisposes patients to many complications, and one 
of the life-threatening complications of MV is 
Ventilator-associated pneumonia (VAP). The risk of 
VAP is highest immediately after intubation and 
steadily increases after that. Even though broad-
spectrum antibiotics had been given to all patients but 
keeping in view concomitant immunosuppressant 
treatment all patients who received MV succumbed. 
Contrary to these three patients who didn’t 
receive MV, despite their active disease survived after 
PH episodes were aggressively managed. PH was the 
first presentation of SLE in four patients in our study 
and 3 of them had seizures in addition to PH. Their 
shortness of breath progressively deteriorated and 
required mechanical ventilation meaning thereby that 
PH can present irrespective of the duration of SLE as 
described in the literature [12], [13]. Even pulmonary 
haemorrhage in SLE can present without extra 
pulmonic manifestation of SLE as reported by 
Bajantari et al., [14]. 
Patients with the associated neuropsychiatric 
manifestation of SLE had a poor outcome in this 
study. The data on 21 Korean patients by Kwok et al., 
[15], revealed that SLE patients with neuropsychiatric 
manifestation were at an increased risk for developing 
PH. Our results are in coherence with their study. 
Renal impairment was associated with the majority of 
patients with PH in this study. Similar results were 
demonstrated by Chang et al., [16]. 
The profile of autoantibodies in our study 
including anti-DNA, lupus anticoagulant, 
anticardiolipin, anti-Sm, anti-Ro and anti-RNP were 
similar in patients with PH compared with SLE 
patients without PH. Hence these may not serve as 
biomarkers to predict PH in SLE. None of our patients 
had thrombocytopenia or deranged coagulation. 
However, all our patients had hypocomplementemia, 
and overwhelming sepsis contributed towards 
mortality in 3 patients. In a study data on 50 patients 
with pulmonary haemorrhage in SLE the bivariate 
analysis, factors associated with mortality were high 
Acute Physiology and Chronic Health Evaluation II 
scores, the requirement of mechanical ventilation, 
infections, renal failure and thrombocytopenia [17].  
All patients in our study cohort received pulse 
Methylprednisolone which has been shown to provide 
a survival advantage compared to prednisone 1 mg/kg 
[1]. In our study 4 patients (33%) were given 
plasmapheresis and one of them survived, but it is 
difficult to assess its utility alone. Intravenous 
immunoglobulin was given to 6patients (50%) in our 
study and of these, a 26-year-old female patient 
survived as shown in Table 2, and 3. This is not 
sufficient to prove the efficacy of IVIG but in a 
retrospective study by Shen et al., [17], the data on 29 
SLE patients with PH, authors advocated early 
aggressive management with high-dose steroids, 
intravenous immunoglobulin and cyclophosphamide. 
Infections have been reported by different 
series as an important factor associated with PH [18], 
[19]. In our study bronchoalveolar lavage (BAL) in 
three patients grew Acinetobacter species and BAL 
was sterile in rest of the patients. It is difficult to 
separate whether the infections occurred at the time 
of diagnosis of PH or after this complication. In a 
study by Rojas-Serrano et al., [18] data on 14 events 
of PH in SLE, evaluated during the first 48h with 
bronchoscopy and bronchoalveolar lavage, showed 
the presence of infection in 57%; of the patients 
leading to the observation that an infection could be a 
precipitating or contributing factor. Thus it is prudent 
to mention that all efforts must be utilised to identify 
and treat infection in a given case of PH. 
Despite aggressive treatment the outcome in 
our study was poor as only 3 patients (25%) survived 
which is, however higher than reported by Marino et 
al., [19]. Various experimental attempts to treat this 
devastating complication have been attempted 
recently in which Umbilical cord-derived mesenchymal 
stem cell transplantation (UC-MSCT) has been shown 
to be effective in the treatment of four SLE patients 
with PH. Authors concluded that UC-MSCT could be 
applied as a salvage strategy for SLE patients with PH 
[20]. However, the data is too small, and the 
availability of this technique is not universal. In 
another study data on 21 patients from China, 
Bronchoalveolar lavage in combination with high-dose 
pulse therapy of methylprednisolone was found to be 
superior to methylprednisolone alone. The authors 
observed a statistically significant difference between 
the two groups. Broncho alveolar lavage alleviated 
hypoxemia and dyspnea in patients with PH [21]. 
 To conclude, PH is a devastating 
complication of SLE, and despite aggressive 
treatment mortality remains high. Our study showed 
that the requirement of mechanical ventilation during 
the disease and association of neuropsychiatric 
manifestations and renal impairment predicted 
mortality in patients with PH. Further studies may be 
carried out to confirm the association. 
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